2019
DOI: 10.1016/j.ajoc.2019.100563
|View full text |Cite
|
Sign up to set email alerts
|

A new mutation in the PAX2 gene in a Papillorenal Syndrome patient

Abstract: PurposeTo present a new mutation in a patient with Papillorenal Syndrome (PAPRS).ObservationsPAPRS is an autosomal dominant disease that involves ocular and renal abnormalities. We present a patient with PAPRS with a genetically diagnosed PAX2 and new pathogenic mutation. A complete ophthalmological, neurological, nephrological and Ears-Nose-Throat (ENT) examination were undertaken. The patient suffered from Focal Segmental Glomerulosclerosis (FSGS) and some typical ophthalmological signs of PAPRS, including o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 16 publications
0
3
0
Order By: Relevance
“…However, the relationship between PAX2 variants and C1q nephropathy is still unclear. It is recognized that PAX2 variants are one of the important causes of FSGS, as reported by many studies ( Rachwani Anil et al, 2019 ; Vivante et al, 2019 ; Nagano et al, 2020 ). The systemic activation of complement in primary FSGS has been identified ( Huang et al, 2020 ).…”
Section: Discussionmentioning
confidence: 92%
“…However, the relationship between PAX2 variants and C1q nephropathy is still unclear. It is recognized that PAX2 variants are one of the important causes of FSGS, as reported by many studies ( Rachwani Anil et al, 2019 ; Vivante et al, 2019 ; Nagano et al, 2020 ). The systemic activation of complement in primary FSGS has been identified ( Huang et al, 2020 ).…”
Section: Discussionmentioning
confidence: 92%
“…A follow-up study in a pediatric cohort of steroid-resistant nephrotic syndrome and FSGS presented additional evidence of phenotypic expansion of extremely rare pathogenic PAX2 SNVs with the identification of heterozygous missense SNVs in 1.3% of cases [12]. Since the publication of these landmark papers, others, too, have reported on the incidence of PAX2 mutations in nonsyndromic FSGS (see Table 1) [35‒42].…”
Section: Pax2: a Kidney Development Gene Attributed To Cause Isolated...mentioning
confidence: 99%
“…Refractive error is common [ 39 ]. Complications include perifoveal splitting, optic nerve atrophy and bilateral glaucomatous cupping [ 34 , 35 ]. There is no treatment.…”
Section: Common Ocular Abnormalities In Genetic Forms Of Fsgsmentioning
confidence: 99%